The Effect of Social Media Support on Healthy Lifestyle Behaviours
Launched by ISTANBUL UNIVERSITY - CERRAHPASA · May 26, 2025
Trial Information
Current as of June 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how social media, specifically Instagram, can help pregnant women develop healthier lifestyle habits. The goal is to create and share helpful, evidence-based information on Instagram to make it easier for pregnant women to adopt healthy behaviors during their pregnancy. Women participating in the study will be divided into two groups: one group will receive regular pregnancy care along with support through Instagram, while the other group will only receive standard pregnancy care. The trial aims to see if using social media can positively influence health habits in pregnant women, which could lead to healthier families and communities in the long run.
To be eligible for this study, women must be between 18 and 49 years old and in their first or second trimester of pregnancy with a single baby. They should be able to use the internet and have an active Instagram account, and they must be able to read and write in Turkish. Women with serious health conditions or those who have used similar programs before will not be included in the study. Participants can expect to engage with a supportive online community focused on health and wellness during their pregnancy while receiving standard medical care.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • First and second trimester pregnancy
- • 18-49 years old
- • With a singleton pregnancy
- • Able to use web and mobile devices
- • Has an account of the determined social media platform and actively uses it
- • Can read and write Turkish
- • Pregnant women with regular internet access were included in the inclusion criteria of this study.
- Exclusion Criteria:
- • Has a psychiatric problem that prevents communication
- • Have a serious pre-pregnancy condition (heart disease, kidney disease or other chronic disease)
- • Previously used a similar programme or app to change healthy lifestyle habits
- • Risky pregnancies (heart disease, kidney disease or other chronic diseases)
About Istanbul University Cerrahpasa
Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Trial Officials
Neslihan Özcan, Prof. Dr.
Study Director
Istanbul Univercity-Cerrahpasa
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported